Oncology
 |
|
17 february 2020 09:03:22 |
| TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial (British Journal of Cancer) |
|
Tweet |
| 177 viewsCategory: Oncology |
 New survival standards for advanced melanoma (British Journal of Cancer)A census of pathway maps in cancer systems biology (Nature Reviews Cancer) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
